CRISPR-based in situ engineering tumor cells to reprogram macrophages for effective cancer immunotherapy
Meng Lin, Zhenzhen Yang, Yiliang Yang, Yiwei Peng, Jiajia Li, Yitian Du, Qi Sun, Datong Gao, Quan Yuan, Yu Zhou, Xinyi Chen, Xian Qi
Topics & Concepts
CRISPRImmunotherapyCancer immunotherapyIn situCancerTumor cellsCancer researchBiologyChemistryGeneticsGeneOrganic chemistryPhagocytosis and Immune RegulationCAR-T cell therapy researchCRISPR and Genetic Engineering